Six problems with pharma-funded bioethics

Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 35 (1):125-129 (2003)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1016/j.shpsc.2003.12.008

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,197

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Six problems with pharma-funded bioethics.Carl Elliott - 2004 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 35 (1):125-129.
Six problems with pharma-funded bioethics.Carl Elliott - 2004 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 35 (1):125-129.
From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians.Amy Snow Landa & Carl Elliott - 2013 - Journal of Law, Medicine and Ethics 41 (3):673-679.
Industry-funded bioethics and the limits of disclosure.Carl Elliott - 2009 - In Denis Gordon Arnold (ed.), Ethics and the Business of Biomedicine. Cambridge University Press. pp. 150.
Should journals publish industry-funded bioethics articles?Carl Elliott - 2012 - In Elisabeth Airini Boetzkes & Wilfrid J. Waluchow (eds.), Readings in health care ethics. Peterborough, Ont.: Broadview Press. pp. 366--61.
From Bad Pharma to Good Pharma: Aligning Market Forces with Good and Trustworthy Practices through Accreditation, Certification, and Rating.Jennifer E. Miller - 2013 - Journal of Law, Medicine and Ethics 41 (3):601-610.
Drugs and Responsibility--The Foundations and Methods of Pharma-ethics.Wolfgang Wagner & Udo Schuklenk - 1996 - Bioethics 10 (2):170-172.
Drugs and Responsibility-the Foundations and Methods of Pharma-ethics edited by Wolfgang Wagner.U. Schueklenk - 1996 - Bioethics 10:170-172.
Why the Avandia Scandal Proves Big Pharma Needs Stronger Ethical Standards.Robert Baker Sean Philpott - 2010 - Bioethics 24 (8):ii-iii.
Why the avandia scandal proves big pharma needs stronger ethical standards.Sean Philpott & Robert Baker - 2010 - Bioethics 24 (8):ii-iii.
Pharma Goes to the Laundry: Public Relations and the Business of Medical Education.Carl Elliott - 2004 - Hastings Center Report 34 (5):18.
The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects by Roberto Abadie.Robert E. Hurd - 2011 - The National Catholic Bioethics Quarterly 11 (3):583-585.
Parallel Problems: Applying Institutional Corruption Analysis of Congress to Big Pharma.Gregg Fields - 2013 - Journal of Law, Medicine and Ethics 41 (3):556-560.
Review of Donald W. Light and Antonio F. Maturo, Good Pharma: The Public-Health Model of the Mario Negri Institute1. [REVIEW]Jill A. Fisher - 2017 - American Journal of Bioethics 17 (2):W9 - W10.
The dominance of big pharma: power. [REVIEW]Andrew Edgar - 2013 - Medicine, Health Care and Philosophy 16 (2):295-304.

Analytics

Added to PP
2017-02-25

Downloads
18 (#836,359)

6 months
2 (#1,205,524)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Carl Elliott
University of Minnesota

Citations of this work

Constructing Critical Bioethics by Deconstructing Culture/nature Dualism.Richard Twine - 2004 - Medicine, Health Care and Philosophy 8 (3):285-295.
Who Is Buying Normative Bioethics Research?Alexander C. Tsai - 2008 - American Journal of Bioethics 8 (8):62-63.

View all 7 citations / Add more citations

References found in this work

No references found.

Add more references